For citations:
Tavlueva E.V., Zernova E.V., Kutepova M.P., Kostina N.E., Lesina V.S., Mould D.R., Ito K., Zinchenko A.V., Dolgorukova A.N., Nikolskaya M.V., Lemak M.S., Filon O.V., Samsonov M.Yu. CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19. Pharmacy & Pharmacology. 2022;10(5):460-471. https://doi.org/10.19163/2307-9266-2022-10-5-460-471
Views PDF (Eng): 199
Email this article 